Abstract Details

Title Comparing Cost-Effectiveness Models for MS Disease-Modifying Agents: Different Inputs and Assumptions Produce Different Conclusions

Topic Neuroepidemiology/Health Services and Outcomes Research

Presentation(s) (-)

Poster/Presentation
Number 131

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Katia Noyes (University of Rochester School of Medicine)	No disclosure on file
Julia Button (Johns Hopkins School of Medicine)	No disclosure on file
Martin Daumer, PhD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Robert G. Holloway, MD, MPH, FAAN (University of Rochester Medical Center)	Dr. Holloway has nothing to disclose.
	No disclosure on file
Deborah M. Miller, PhD (Cleveland Clinic Foundation)	Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Steven R. Schwid, MD, FAAN (University of Rochester Dept. Neurology)	No disclosure on file
	No disclosure on file

��ɫ��